Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Family Medicine
 Disease Category: Lupus
Location: United States, NY

Trial Information

Are You One of the 5 Million Individuals Living with Lupus?

If you are one of these individuals, we invite you to consider participating in the ILLUMINATE Research Study Program. The ILLUMINATE Program is evaluating a new investigational medication for systemic lupus erythematosus (SLE), the most common form of lupus. We are one of many sites across the country taking part in this research.
If you or someone you know:

  • is 18 years of age or older and
  • has been diagnosed with SLE
then participation in this clinical research program could be an option for you. To determine if you may qualify to take part, our doctors and nurses will perform additional tests and health assessments. Individuals who qualify will receive study medication and all study-related care at no charge. Reimbursement for study-related travel and time will be provided. Some standard lupus medications will also be permitted during study participation.

Please contact us to see if you qualify

Becky Ricotta, Research Administrator
AAIR Research Center
300 Meridian Centre, Suite 305
Rochester, NY 14618
Phone: 585-442-1980
Fax: 585-442-1585
Email: research@aair.info

View Map

Research Center Information: AAIR Research Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.